Estimate Recalculated Nov 1, 2024 10:01AM EST
Kevin F McLaughlin has an estimated net worth of $23.6 Million. This is based on reported shares across multiple companies, which include Vericel Corp, Decibel Therapeutics, Inc., ACCELERON PHARMA INC, PRAECIS PHARMACEUTICALS INC, and Invivyd, Inc..
Kevin F McLaughlin's CIK is 0001214938
2015 was Kevin F McLaughlin's most active year for acquiring shares with 25 total transactions. Kevin F McLaughlin's most active month to acquire stocks was the month of November. 2015 was Kevin F McLaughlin's most active year for disposing of shares, totalling 59 transactions. Kevin F McLaughlin's most active month to dispose stocks was the month of November. 2020 saw Kevin F McLaughlin paying a total of $3,573,047.72 for 151,328 shares, this is the most they've acquired in one year. In 2020 Kevin F McLaughlin cashed out on 215,329 shares for a total of $11,450,947.89, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!